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Abstract
Neurocognitive decline, including deficits in motor learning, occurs in the presymptomatic
phase of Huntington’s disease (HD) and precedes the onset of motor symptoms. Findings
from recent neuroimaging studies have linked these deficits to alterations in fronto-striatal
and fronto-parietal brain networks. However, little is known about the temporal dynamics of
these networks when subjects approach phenoconversion. Here, 10 subjects with pre-
symptomatic HD were scanned with 15O-labeled water at baseline and again 1.5 years later
while performing a motor sequence learning task and a kinematically matched control task.
Spatial covariance analysis was utilized to characterize patterns of change in learning-
related neural activation occurring over time in these individuals. Pattern expression was
compared to corresponding values in 10 age-matched healthy control subjects. Spatial
covariance analysis revealed significant longitudinal changes in the expression of a specific
learning-related activation pattern characterized by increasing activity in the right orbitofron-
tal cortex, with concurrent reductions in the right medial prefrontal and posterior cingulate
regions, the left insula, left precuneus, and left cerebellum. Changes in the expression of
this pattern over time correlated with baseline measurements of disease burden and learn-
ing performance. The network changes were accompanied by modest improvement in
learning performance that took place concurrently in the gene carriers. The presence of
increased network activity in the setting of stable task performance is consistent with a dis-
crete compensatory mechanism. The findings suggest that this effect is most pronounced in
the late presymptomatic phase of HD, as subjects approach clinical onset.
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Introduction
The acquisition, consolidation and retrieval of serial movements are essential in everyday life
and behavioral adaptation. A large body of functional imaging studies investigated the neuro-
nal correlates of motor sequence learning in healthy subjects and individuals with brain disease
[1–3]. According to a comprehensive systems-based model of this cognitive process, the acqui-
sition and retrieval of sequential information is mediated by specific cortico-striatal, cerebello-
thalamo-cortical, and cortico-cortical projection pathways. In this context, neurodegenerative
disorders involving the basal ganglia can disrupt the function of learning-related pathways
linking the affected regions with the cerebral cortex, leading to compromised task performance.
By the same token, such changes may be accompanied by compensatory increases in task-
related activity in regions unaffected pathologically by the disease process. In this vein,
increases in learning-related activation and functional connectivity in cerebellar pathways have
been consistently discerned in individuals with basal ganglia disorders allowing for perfor-
mance to be maintained at or near normal levels [4, 5]. Indeed, we have found that compensa-
tory responses of this type can persist for extended periods of time in subjects with early
Parkinson’s disease [6].
Whether analogous compensatory changes are evident in individuals with preclinical/pro-
dromal disease is not known at either the regional or systems level. More specifically, informa-
tion is limited regarding the neural substrates underlying the development of cognitive deficits
prior to clinical onset. To address these issues, we examined the changes in motor sequence
learning and associated neural activation responses that took place over time in a cohort of pre-
clinical carriers of the Huntington’s disease (pHD) mutation. The diagnosis of HD relies on the
presence of overt motor signs with chorea being the main feature. Nonetheless, neurocognitive
deficits appear commonly in the presymptomatic stage of the disease [7]. Indeed, alterations in
fronto-striatal and fronto-parietal connectivity have been linked to these deficits [8, 9], particu-
larly in relation to sequence learning [10]. In general, cognitive dysfunction becomes more
severe as subjects approach phenoconversion [7, 11]. That said, few studies have longitudinally
evaluated task-related activation responses in this population.
In this study we utilized 15O-labeled water (H2
15O) positron emission tomography (PET) in
conjunction with network analysis to identify compensatory changes in learning-related neural
activation that take place with the progression of preclinical HD.
Material and Methods
Subjects
Ten right-handed presymptomatic HD subjects (5 men and 5 women; age 47.3±10.7 (mean
±SD) years; mean CAG repeat length 41.6±1.8) were recruited through the Movement Disor-
ders Center of the Northwell Health. The predicted number of years to clinical onset (YTO)
was estimated for each subject based on baseline CAG repeat length and age [12]. The average
time to predicted onset for the whole group was 10.6±9.0 years. Two of the subjects phenocon-
verted during the follow-up period (see below). For those subjects, we used the actual number
of years elapsed from baseline to the time of clinical diagnosis.
All subjects were assessed clinically at baseline and follow-up (interval: 1.5±0.1 years) by a
neurologist experienced in the assessment and diagnosis of pHD subjects (A.F.). At baseline,
none of the subjects exhibited sufficient signs and symptoms for a clinical diagnosis of HD to
be made. Nonetheless, two of the subjects were diagnosed at the 18-month follow-up time
point. United Huntington’s Disease Rating Scale (UHDRS) motor scores did not differ over
time for the subjects (8.3±10.5 vs. 11.3±11.6; p = 0.137, Wilcoxon signed-rank test). In this
Motor Sequence Learning in Huntington's Disease
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study, the pHD data were compared to baseline measurements from 10 right-handed healthy
control (HC) subjects (6 men and 4 women; age 46.8±13.3 years). Baseline activation data
from the pHD subjects have been reported previously [10].
Behavioral tasks
All subjects performed two motor tasks during each session of PET scanning: a motor sequence
learning task (LEARN) and a kinemetically equivalent motor execution task (MOVE) [13].
Briefly, in both tasks, the dominant right hand was used to move a cursor on a digitized tablet.
Out and back reaching movements were executed from the central position toward one of
eight radial targets displayed on the screen. In LEARN, the eight targets appeared in pseudo-
randomized order without repeating elements at a 1s tone interval. Subjects were asked to learn
the presented target sequence and to reach the targets in synchrony with the tone. The sum of
all correctly anticipated targets in each LEARN run was computed and defined as the retrieval
index (RI). Thus, a high RI reflects good learning performance. InMOVE, a kinematically con-
trolled motor execution reference task, the targets appeared in a predictable counterclockwise
order at 1s intervals matched to a cueing tone. Subjects were instructed to reach the targets in
synchrony with the tone such that the movement had to be initiated before the target appeared.
In addition, subjects were scanned in a non-movement, non-learning resting (REST) condi-
tion, in which they were instructed to watch the targets without moving or attempting to learn
a sequence. The subjects were trained outside the scanner one day prior to the scan to ensure
stable task performance during the imaging epoch.
Positron emission tomography
All pHD subjects underwent H2
15O PET at baseline and follow-up; the healthy control subjects
were scanned only at baseline. Subjects fasted for a minimum of 6 hours before imaging.
Scanning was conducted using the GE Advance tomograph (GE Healthcare) in 3D mode as
described previously [10], while the subjects performed the LEARN,MOVE, and REST tasks
in randomized order. The pHD subjects performed theMOVE and LEARN tasks twice at both
baseline and follow-up. Thus, 20 LEARN/MOVE scan pairs were available for analysis at each
of the two longitudinal pHD time points. However, because of fatigue, one of the healthy sub-
jects performed only a single trial of each task, which resulted in 19 LEARN/MOVE scan pairs
for the control group. All but one of the pHD subjects were scanned twice at each time point in
the REST condition. Eight of the 10 control subjects were scanned twice in the REST condi-
tion; the remaining two subjects were scanned only once in this condition.
Relative regional cerebral blood flow (rCBF) was estimated using a modified slow bolus
method [14], in which up to 12 mCi of H2
15O in 4 mL saline was injected by an automatic
pump in 16 sec (15 mL/min) followed by a manual 3 mL saline flush. There was a time delay of
approximately 17 sec in arrival of radioactivity in the brain, and the time from rise to peak
count rate was 35–40 sec. The timing of task initiation was individually adjusted so that the
arrival of radioactivity occurred approximately 10 sec after the start of the task. PET data acqui-
sition began at the time of radioactivity arrival in the brain and continued for 80 sec. The end
of task thus coincided with the end of data acquisition. The interval between successive H2
15O
administrations was 12 min to allow for the decay of radioactivity. Two H2
15O boluses were
injected in each task condition with a maximum of 16 boluses per study for each subject. The
total effective dose equivalent of 192 mCi of H2
15O was 0.81 rads or 0.0081 Gy. The maximal
exposure was 0.63 rads (0.0063 Gy) for reproductive organs and 1.57 rads (0.0157 Gy) for criti-
cal organs, which were substantially lower than the limit (5.0 rads or 0.05 Gy) of dose exposure
per study for each subject.
Motor Sequence Learning in Huntington's Disease
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Ethical permission for the PET studies was obtained from the Institutional Review Board of
Northwell Health (Manhasset, NY). Written consent was obtained from each subject after
detailed explanation of the procedures.
Data analysis
Preprocessing. Imaging data was preprocessed using SPM 5 (Wellcome Department of
Cognitive Neurology, London, UK) implemented in MATLAB (Mathworks, Sherborn, MA).
All scans from each pHD subject were spatially realigned across conditions (REST,MOVE and
LEARN) and time points to remove possible mismatch due to subject motion between imaging
sessions and repositioning errors in repeat studies. All images were averaged after the spatial
realignment to produce a mean image with higher signal-to-noise ratio. Realigned images were
then spatially normalized to the standard SPM PET template via the mean image. The resulting
images were smoothed by a 10 mm Gaussian filter in 3D space.
At each time point, LEARN-MOVE subtraction images were constructed using an in-house
program (ScAnVP 5.9.1, available at www.feinsteinneuroscience.org) to map learning-specific
activation responses on a voxel-by-voxel basis. Before subtraction, images were masked by
applying a whole brain gray-matter mask; an adjustment for the global mean was performed
for each image. Since the pHD subjects performed two runs of each task, 20 (10×2) subtraction
images were constructed for the baseline and follow-up sessions. In this way, we assessed the
longitudinal changes in brain activation in the pHD subjects that were specifically associated
with learning, as opposed to less specific motor execution effects.
Network analysis. To identify significant spatial covariance pattern(s) associated with com-
pensatory network-level responses during sequence learning, we sought: (1) topographies with
longitudinal increases in task-specific (LEARN-MOVE) activation responses over time in the
H2
15O PET data; and (2) patterns in which subject expression increased in proportion to base-
line disease burden. Thus, we used Ordinal Trends Canonical Variates Analysis (OrT/CVA, soft-
ware available at https://www.nitrc.org/projects/gcva_pca) [13, 15], a form of supervised
principal component analysis (PCA), to isolate potential compensatory topographies in the
pHD subjects. Specifically, we sought covariance patterns with increasing expression over time
(i.e., TP2 TP1), such that subject scores were greater for the mutation carriers who were nearer
to phenoconversion. In other words, we endeavored to identify activation networks for which
compensatory responses were largest in individuals with greatest underlying disease burden.
To this end, we used OrT/CVA to identify a set of one or more linearly independent
(orthogonal) spatial covariance patterns displaying monotonic changes in expression across
conditions or time points. In contrast to univariate analytic approaches comparing group
means, this multivariate approach identifies ordinal trends in the data, i.e., monotonic
increases or decreases in pattern expression across conditions/time points with few if any indi-
vidual case violations. Once a significant spatial covariance pattern is identified, subject scores,
representing network expression in individual cases, are computed for scans acquired at the
various time points or experimental conditions [13, 16]. The significance of subject score dif-
ference between groups/conditions is determined using non-parametric permutation tests. The
reliability of the voxel weights (regional loadings) on the identified network topography is
determined by bootstrap resampling procedures [17].
In the current study, OrT/CVA was applied to subtraction images (LEARN-MOVE) from
the pHD subjects obtained at baseline and at the 18-month follow-up time point. In a second
step, subject scores for the resulting principal component (PC) patterns were entered into a
multiple regression model using baseline YTO as a measure of disease burden for each individ-
ual. Compensatory learning-specific activation topographies were defined as those with
Motor Sequence Learning in Huntington's Disease
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significantly increasing subject scores over time, for which individual differences in expression
correlated positively with baseline YTO values. Model selection was based on the number of
PCs associated with the smallest value for the Akaike Information Criterion [18].
For pattern validation, the subtraction images were permuted across time points to generate
a null-hypothesis for the r2-value of the YTO-fit. Significance was assumed for p<0.05 (1,000
iterations). The YTO-fitted OrT/CVA pattern topography was displayed at a voxel-weight
threshold of z = 2.33 (p<0.01, cluster cutoff = 100 voxel). Only voxels found to be reliable on
bootstrap resampling (magnitude of the inverse coefficient of variation (|ICV|)> 1.96, p<0.05;
1,000 iterations) were considered as contributing network regions.
After network identification, pattern expression was prospectively computed in theMOVE
and LEARN scans of the pHD subjects and controls using an automated voxel-based proce-
dure [19]. Subject scores computed in theMOVE scans of the healthy control subjects were
used to z-transform the LEARN andMOVE values for the pHD and control subjects, such that
the mean of the controlMOVE scans was zero with a standard deviation of one. After stan-
dardization, subject scores of theMOVE scans were subtracted from the corresponding scores
in the LEARN condition. As described above, the resulting difference score reflects the learn-
ing-related network activation response. In a second step, the longitudinal change of this
response between baseline and follow-up in the pHD group was computed ([LEARN-
MOVE]TP2-[LEARN-MOVE]TP1) and correlated with baseline YTO values.
Lastly, to evaluate potential longitudinal changes in network expression occurring indepen-
dent of task condition, we computed corresponding subject scores in the REST scans obtained
from the pHD and healthy control subjects. As above, expression values computed in the con-
trol subjects were used to standardize the corresponding measures computed in the pHD
subjects at the two time points. Longitudinal changes in resting network expression were calcu-
lated by subtracting the z-scores of the baseline scans from those measured at follow-up
(RESTTP2-RESTTP1). For subjects with more than one scan per condition, the corresponding
network scores were averaged before further analysis.
Regional analysis. For post-hoc analysis, longitudinal changes of rCBF were evaluated by
centering a 5 mm sphere at the peak voxel of each network region. Regional values were measured
in each region in the LEARN andMOVE scans of the pHD subjects at the two time points, and
in the healthy subjects at baseline. rCBF values were adjusted for the global mean of each scan to
account for potential alterations across scans. The learning-related rCBF response (LEARN-
MOVE) was calculated for each scan pair. As in the network analysis, the longitudinal change in
the learning-related brain activation response ([LEARN-MOVE]TP2-[LEARN-MOVE]TP1) was
computed in the pHD subjects and correlated with baseline YTO values. Network regions dis-
playing a positive correlation between learning-related activation responses and YTO corre-
sponded to positive loadings (“red” regions) on the identified covariance pattern; those with
negative correlations corresponded to negative loadings (“blue” regions) on the same pattern.
Statistical analysis. SPSS software was used for statistical tests. Non-parametric Wilcoxon
signed-rank tests and Mann-Whitney U-tests were utilized for group comparisons where
appropriate. Correlations of subject scores and rCBF values with YTO and behavioral measures




Measures of learning performance and corresponding changes over time are displayed in Fig 1
and Table 1. No significant differences in learning performance, as measured by the RI, was
Motor Sequence Learning in Huntington's Disease
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present at baseline between HDmutation carriers and the healthy control subjects (pHD: 18.0
±18.9; HC: 31.8±24.7, p = 0.307; Mann-Whitney U-test). Network analysis (see below) revealed
that the pHD cohort was comprised of two discrete groups based upon proximity to phenocon-
version (see below). Subjects in the first group were chronologically near phenoconversion
(nearPC (n = 7): age 50.3±8.6 years; YTO11); the remaining subjects were far from pheno-
conversion (farPC (n = 3): age 43.3±13.6 years; YTO>11). Subjects in the nearPC group exhib-
ited lower baseline learning performance than the cohort as a whole. Even so, mean RI in this
group did not differ significantly from control values (nearPC: 11.9±13.6; HC: 31.8±24.7,
p = 0.130). Borderline improvement in learning performance was seen over time for the entire
Fig 1. Motor learning performance in patients with presymptomatic Huntington’s disease (pHD) and
healthy controls (HC). pHD subjects showed a slight improvement in learning performance at follow-up (18
months). Note that individuals with low learning performance at baseline (“bad learners,” BL) showed
substantial improvement at follow-up. In contrast, “good learners” (GL) showed normal learning performance
at baseline and did not change over time. Subjects with relatively high disease burden (nearPC) showed
slightly lower learning performance at baseline compared to the overall group. [Bars represent group mean
values. Error bars indicate SEM.]
doi:10.1371/journal.pone.0154742.g001
Table 1. Longitudinal changes in learning performance and network expression.
RETRIEVAL INDEX NETWORK EXPRESSION
TP1 TP2 Delta TP1 TP2 Delta
pHD 18.0±18.9 24.0±16.6 6.0±9.0a -0.7±1.1 0.5±0.8 1.3±1.9
nearPC 11.9±13.6 17.6±10.0 5.8±10.8 -1.3±0.6b 0.9±0.7b 2.2±1.2a
BL 4.1±2.1 14.7±7.3 10.6±7.1a -1.5±0.6b 1.2±0.4b 2.8±0.9a
GL 31.9±17.7 33.3±18.8 1.4±8.9 0.1±0.8 -0.2±0.4 -0.3±1.1
HC 31.8±24.7 n/a n/a -0.1±0.4 n/a n/a
pHD = presymptomatic Huntington’s disease, nearPC = pHD subjects approaching phenoconversion (11 years to predicted motor onset), BL = “bad
learners” showing poor learning performance at baseline, GL = “good learners” showing good learning performance at baseline (see text for details),
HC = healthy controls.
ap<0.05, TP1 compared to TP2.
bp<0.005, compared to HC.
doi:10.1371/journal.pone.0154742.t001
Motor Sequence Learning in Huntington's Disease
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pHD cohort (Delta RI (TP2-TP1): 6.0±9.0, p = 0.047; Wilcoxon signed-rank test). A similar,
albeit non-significant trend was observed in the nearPC group (Delta RI (TP2-TP1): 5.8±10.8,
p = 0.128). Of note, learning performance did not differ from normal at the second time point
in either of the two pHD groups (p>0.49, compared to HC).
We additionally related the longitudinal changes in network activity to baseline learning
performance. Using the RI median value of 8.8 for the pHD group, five gene carriers were clas-
sified as “good learners” (GL) and five as “bad learners” (BL) based on their baseline RI values.
Whereas, at baseline, learning performance was intact in the GL subjects (RI: 31.9±17.7,
p = 0.902; Mann-Whitney U-test), the BL subjects exhibited a marginal reduction in this mea-
sure (RI: 4.1±2.1, p = 0.075). Interestingly, learning performance improved over time in the BL
group (Delta RI (TP2-TP1): 10.6±7.1, p = 0.043; Wilcoxon signed-rank sum test), but no con-
current change was evident in the GL subjects (Delta RI (TP2-TP1): 1.4±8.9, p = 0.500). Learn-
ing performance at TP2 did not differ from normal in either group (p>0.46). Notably, the BL
group was comprised of the five pHD subjects who were nearest to phenoconversion (YTO: 3.3
±2.3, range 1.4–7.0). By contrast, the GL group was comprised of individuals far from the
expected time of phenoconversion (YTO: 17.8±6.8, range 11.0–25.0).
Network analysis
Network analysis revealed a significant pattern of learning-related activation characterized by
monotonic increases in subject expression over time that correlated with baseline YTO values.
This spatial covariance pattern (Fig 2) was characterized by increased learning-related activa-
tion in the right orbitofrontal cortex (BA11), associated with reductions in the right medial pre-
frontal cortex (BA10) and posterior cingulate (BA31) region, and in the left precuneus (BA7),
insula (BA13), and cerebellum (Lob VIIA,VIIIA/B, IX). Voxel weights in these regions were
Fig 2. Motor learning-related spatial covariance pattern in subjects with presymptomatic Huntington’s disease. This pattern was characterized by
increasing activity in the right orbitofrontal cortex (OFC; BA11) and concurrent relative decreases in the right medial prefrontal cortex (mPFC; BA10), left
insular cortex (BA20), left precuneus (BA7), left cerebellum and the right posterior cingulate cortex (PCC; BA31). [The “red” blob indicates increasing
activity, “blue” blobs show decreasing activity. The colored bar displays the z-score range; coordinates are displayed in MNI standard space.]
doi:10.1371/journal.pone.0154742.g002
Motor Sequence Learning in Huntington's Disease
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found to be reliable by bootstrap estimation (|ICV|>2.81; p<0.005; 1,000 iterations), and
validity of subject scores was confirmed by permutation test (p<0.001).
In keeping with the proposed compensatory role of this network in pHD subjects, changes
in pattern expression over time (Fig 3A) correlated with baseline disease burden (r = 0.973,
p<0.0001; Spearman correlation). Thus, the most prominent longitudinal increases in network
activity were observed in the pHD subjects who were nearest phenoconversion. Indeed, the
nearPC subjects displayed substantial increases in network expression (mean change = +2.2 z-
scale units) over time, whereas the farPC subjects exhibited small declines (|z|<1.5) in activity
over the same time period. Even so, the correlation between the network changes and baseline
YTO remained significant (r = 0.919, p = 0.003) when the analysis was limited to the nearPC
group.
Further analysis revealed a marginal increase in network activity (p = 0.093) over time (Fig
3B; Table 1) for the overall pHD cohort. This result remained significant (p = 0.018) when only
nearPC subjects were included in the analysis. Network activity for the overall group did not
differ from control values at either time point (p>0.17). Nonetheless, in the nearPC group, net-
work activity was abnormally reduced at baseline (p = 0.002). By contrast, network activity at
the second time point was elevated above normal (p = 0.001) in these subjects.
These findings were similar when the pHD subjects were grouped according to their base-
line learning performance. Thus, the BL subjects exhibited low network expression at baseline
(p = 0.003, relative to HC), which increased significantly over time (p = 0.043) reaching super-
normal levels (p = 0.002, relative to HC) at follow-up. By contrast, network expression in the
GL subjects did not differ from normal at either time point (p>0.17) and did not change signif-
icantly over time (p = 0.500). Indeed, change in network expression over time was significantly
greater in BL compared to GL subjects (group × time interaction effect: F(1,8) = 23.234,
p = 0.001; RMANOVA). No correlation was present (p>0.72) between increases in network
expression over time and concurrent changes in learning performance in the pHD cohort. Of
Fig 3. Longitudinal changes in network expression are associated with disease burden and learning performance at baseline. (A) Longitudinal
changes in network expression (LEARN-MOVE)TP2-(LEARN-MOVE)TP1 (see text) correlated with baseline disease burden as expressed by the
predicted years to disease onset (YTO). Note that the three subjects far from predicted motor onset exhibited relatively stable network expression over
time, whereas subjects approaching phenoconversion (nearPC) showed a significant increase in network activity. Of note, the association of increased
network expression and YTO remained significant in nearPC subjects only (red trend line). (B) Learning related brain activation (LEARN-MOVE, see text
for details) increased significantly in nearPC subjects and individuals exhibiting poor learning performance at baseline (“bad learners,” BL). In contrast,
individuals with normal learning performance (“good learners,”GL) did not show changes in network expression over time. Baseline network expression
in nearPC and BL was significantly lower compared to healthy controls (HC), whereas subject scores exceeded the normal range at follow-up in these
individuals. [*p<0.005, compared to HC. Bars represent group mean values. Error bars indicate SEM.]
doi:10.1371/journal.pone.0154742.g003
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note, network expression levels measured in the resting state did not change over time in any
of the pHD groups (p>0.13), and did not differ from healthy control values at either time
point (p>0.17). Likewise, longitudinal changes in network activity measured in the resting con-
dition did not correlate with baseline measures of disease burden (p>0.75) or learning perfor-
mance (p>0.17).
Regional analysis
The results of regional analysis are summarized in Table 2. Learning-related rCBF activation
responses in the right orbitofrontal cortex (Fig 4A) correlated directly (r = 0.881, p = 0.001)
with YTO values, whereas significant inverse correlations (Fig 4B and 4C) were present in the
right medial frontal region (r = -0.699, p = 0.024) and in the left insula (r = -0.650; p = 0.042).
A trend-level relationship (Fig 4D) between these variables (r = -0.602; p = 0.066) was noted in
the right posterior cingulate cortex. Of the network regions, significant longitudinal changes in
learning-related rCBF were present in the left insula (Fig 4E), in which local activation
responses declined over time (p = 0.028). Compared to the healthy control subjects, baseline
rCBF in this region was abnormally elevated in the pHD subjects (p = 0.029), declining toward
normal by the second time point (p = 0.971, relative to HC). Similarly, a marginal decline in
learning-related rCBF was also observed in the right precuneus (p = 0.047). However, rCBF at
this node did not differ from normal at either time point (p>0.12). Changes in learning-related
rCBF over time were not significant (p>0.20) for the other network regions. Changes in learn-
ing-related activity recorded over time in the network regions did not correlate significantly
(p>0.07) with concurrent changes in task performance.
Discussion
We identified a learning-related functional brain network defined by longitudinally covarying
changes in the activation responses in presymptomatic HD subjects. Cognitive impairment
Table 2. Regional activity changes at the network nodes.
NETWORK NODES rCBF rd p
MNI BA Size Tmax HC pHD TP1 pHD TP2 pHD TP2-TP1
Positive
R OFC 2 56–16 11 117 3.51 -2.3±3.4 -2.3±3.0 -2.0±3.3 0.4±5.4 0.881 0.001
Negative
L Insula -42–20 16 20 148 3.75 -2.7±3.3 0.7±2.7b -2.4±2.3 -3.1±3.7c -0.650 0.042
R mPFC 26 42 32 10 208 3.64 -0.1±1.8 2.2±3.9 0.3±2.8 -1.8±4.8 -0.699 0.024
R PCC 8–22 46 31 278 3.17 -1.9±4.1 -0.1±4.1 -1.3±2.1 -1.2±4.4 -0.602 0.066
L Prec -6–62 48 7 170 3.49 1.4±3.1 3.9±3.0 1.0±2.2 -2.9±4.1c -0.416 0.232
L Cer -14–46–50 IX 297 4.04 1.3±1.5 0.0±4.4 -2.8±3.6 -2.8±6.4 -0.540 0.107
VIIA/B
VIIAa
OFC = orbitofrontal cortex, Insula = insular cortex, mPFC = medial prefrontal cortex, PCC = posterior cingulate cortex, Prec = precuneus,
Cer = cerebellum, rCBF = learning-related (MOVE-LEARN) change in normalized regional cerebral blood flow at each time point (TP) and for healthy
controls (HC), pHD TP2-TP1 = longitudinal change in the learning related activation response (see text for details). Values are presented as mean±SD.
aLobules according to the atlas of Schmahmann [42].
bp<0.05, compared to HC.
cp<0.05, TP1 compared to TP2.
dCorrelation of pHD TP2-TP1 with baseline years-to-onset.
doi:10.1371/journal.pone.0154742.t002
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including deficient motor learning performance often precedes the onset of motor symptoms
in HD mutation carriers [10, 20]. Indeed, altered cognitive function can emerge decades before
the predicted time of diagnosis, and changes in regional brain function can antecede these
behavioral changes [21]. That said, recent data suggest that cognitive decline and concurrent
brain changes are most prominent in the decade preceding clinical diagnosis [7, 22–24]. More-
over, brain atrophy and functional decline progress faster in gene carriers with higher disease
Fig 4. Regional correlations of learning-related brain activation changes with disease burden at baseline. At the region level, significant
correlations between learning-related regional cerebral blood flow (rCBF) responses and baseline disease burden (YTO) were observed in the right
orbitofrontal cortex (OFC, BA11,A), right medial prefrontal cortex (mPFC, BA10,B), and left insular cortex (BA20,C). Trend level significance was
reached in the right posterior cingulate cortex (PCC, BA31,D). rCBF responses in the insular cortex exceeded that observed in healthy controls (HC) at
baseline (TP1), and returned to normal at follow-up (TP2) (E). [Bars represent group mean values. Error bars indicate SEM. aCoordinates are displayed in
MNI standard space.]
doi:10.1371/journal.pone.0154742.g004
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burden [22, 24, 25]. In line with these findings, we observed pronounced elevations in network
activity in pHD individuals approaching predicted motor onset.
This increase in network activation was accompanied by concurrent improvement in learn-
ing performance. Although we did not observe a significant correlation of network scores and
retrieval index, this association suggests that the network compensates to some degree for the
decline in learning performance expected based upon disease progression. Thus, the greatest
longitudinal increases in network expression were observed in the mutation carriers with the
largest disease burden and the lowest learning capacity at baseline. Indeed, significant reduc-
tions in network expression were initially present in these individuals, reaching abnormally
elevated levels by the time of follow-up. By contrast, pHD subjects with normal learning per-
formance and low disease burden did not activate this compensatory network. The specificity
of the network changes for motor learning is underscored by the observation that expression
values for the same covariance pattern, computed in resting (non-movement, non-learning)
scans from the same subjects/time points, did not differ from normal, change over time, or cor-
relate with baseline disease burden estimates. Taken together these findings suggest that the
current network is specific for longitudinal learning-related changes in pHD, independent of
overall disease progression. Indeed, this task-specific HD network did not correlate (r = 0.025,
p = 0.403) with the general metabolic progression spatial covariance topography that was
recently characterized in this population [26].
Unexpectedly, we observed a slight but significant improvement of learning performance in
pHD subjects. Although the scans were 1.5 years apart, we cannot exclude a practice effect.
Indeed, it has been reported previously that such a training effect can lead to significant
improvement of cognitive performance in pHD subjects with relatively low disease burden
[27]. In our cohort, the improvement in learning performance was greatest in the pHD subject
with initially poor learning performance. These individuals also had low network expression at
baseline and exhibited large increases in network activity over time. Thus, the data suggest that
cognitive performance has to fall below a certain threshold to activate the compensatory brain
network. In addition, these observations suggest that practice/training may produce improve-
ment in learning in pHD even in individuals close to disease onset.
The learning-related topography included several regions that have been previously associ-
ated with motor learning in healthy subjects [2, 28–30]. In the right orbitofrontal cortex, learn-
ing-related rCBF values increased over time and significantly correlated with baseline disease
burden. By analogy to changes seen at the network level, increasing activity in this region,
which is not typically deployed for motor learning, served a compensatory role. Along these
lines, we have noted an abnormal increase in task-related activation in a similar area in the
baseline scans of this pHD cohort [10]. That said, the other major network regions showed an
inverse correlation with baseline disease burden and tended to exhibit lower learning-related
activity at follow-up than at baseline. Disease progression is a plausible explanation for decreas-
ing activity in these brain areas. We note that these regions are activated during learning in
healthy subjects, with higher rCBF during the performance of LEARN relative toMOVE [28,
31]. The decline in learning-related activation observed in these regions may reflect the incipi-
ent development of HD pathology. Indeed, longitudinal MRI data from these subjects have
revealed ongoing volume loss in a number of relevant brain regions [26].
Moreover, prior structural MRI studies have consistently found volume loss in multiple
brain regions in presymptomatic and early manifest HD. Loss of striatal volume [22, 32] has
been associated with deficits in motor performance [33]. Loss of cortical gray matter volume or
cortical thinning has been found to be most pronounced in the sensorimotor and occipital
regions [34, 35] and has been linked to deficits in motor and cognitive function [33, 36]. While
decreased striatal volume can be observed in gene carriers far from predicted onset of motor
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symptoms [22, 32], loss of cortical volume seems to be pronounced in premanifest subjects
close to phenoconversion [37]. The frontal and temporal areas, however, seem to be largely
spared from atrophy in premanifest HD [35, 37]. In the present study, we observed reduced
learning-related activity in the posterior cingulate cortex, precuneus, and the cerebellum,
regions in which volume loss has been found in premanifest and early manifest HD subjects
[35, 38, 39]. In contrast, the orbitofrontal cortex, a major network node exhibiting increased
activity over time, has been found to be spared from degenerative processes in presymptomatic
gene carriers and is also not typically involved in motor learning [10, 35]. Other network
nodes, i.e., the medial frontal cortex and insular cortex, are likewise not typically affected by
brain atrophy in premanifest HD [35]. Together, these findings suggest that motor learning-
related network activity, though partially linked to concurrent regional volume loss, is unlikely
to be driven entirely by brain atrophy.
We acknowledge some limitations of our study. Firstly, the sample size was relatively
small, and the results therefore have to be interpreted with caution. Because of the small sam-
ple size and high variability of VOI data, no correction for multiple comparisons was applied
to the analyses of regional activity that were limited to the major nodes of the rigorously vali-
dated learning network. That said, the observations are valuable given that to date very few
studies have focused on the longitudinal changes of brain activation that take place in pHD
subjects during cognitive effort [40]. Secondly, the normal volunteers were assessed only at a
single time point. Consequently, we could not directly compare changes in network expres-
sion that took place over time in the two groups. However, it is not likely that learning-
related brain activity changes substantially over an interval of 18 months in healthy, young
individuals. Indeed, in a recent fMRI study, no change in brain activation was present in
healthy subjects repeating an attention task after two years [40]. However, we cannot
fully exclude possible test-retest effects or unspecific activation effects that might have con-
founded network identification. Nevertheless, by implementing a non-learning control task
in the study design, the risk of such effects is substantially diminished as brain activation
caused by movement is the main confounder of all motor learning paradigms. Thirdly, we
chose to use H2
15O PET to study brain activity because it is a direct measure of rCBF with a
better signal-to-noise ratio compared to functional MRI [41]. Nonetheless, due to the small
sample size and the exploratory nature of this study, it might be worthwhile to further exam-
ine and validate the current findings in future functional or perfusion MRI studies with larger
samples.
Finally, we did not observe a linear relationship between learning scores and the brain
changes that occurred at either the region or network levels. Even so, the simultaneous occur-
rence of increasing network activity and improved motor learning is suggestive of such
an association, particularly given the absence of corresponding changes in the resting state.
In this vein, it is conceivable that individual differences in task performance are mediated
by a separate brain network, distinct from that which specifies the behavioral state of the
subject.
Conclusions
In summary, the occurrence of increasing network activity and improved learning performance
that was most pronounced in individuals with low baseline performance and high disease bur-
den is consistent with a compensatory response. At the region level, the orbitofrontal cortex
may play a critical role in mediating this response. The inverse relationship between the net-
work changes and disease burden suggests that this response is most relevant in pHD subjects
nearing phenoconversion.
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